EDSA
Edesa Biotech, Inc.
NASDAQ · Healthcare · Biotechnology · CA
$4.90
+2.84%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-160.0%
Return on equity
-110.9%
Return on assets
-166.0%
Return on invested capital
0.00x
Asset turnover
-$9.0M
Cash from operations
$1.07
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026